Skip to main content

Table 3 Treatment and outcomes

From: In-hospital outcome of patients with culture-confirmed tuberculous pleurisy: clinical impact of pulmonary involvement

 

Isolated pleurisy group (N = 51)

Pleuro-pulmonary group (N = 154)

p value

Anti-tuberculous treatment

46 (90%)

130 (84%)

0.305

Tube thoracostomy or decortication

4 (8%)

24 (16%)

0.163

Days-to-treatment

6 [26.8]

9 [15.6]

0.367

   Within 2 weeks

35 (69%)

86 (56%)

0.264

   More than 2 weeks

11 (21%)

44 (28%)

 

   Not treated

5 (10%)

24 (16%)

 

Residual pleura thickening*

   

   ≥ 10 mm

10 (29%)

24 (35%)

0.542

   < 10 mm

25 (71%)

45 (65%)

 

In-hospital mortality rate

2 (4%)

37 (24%)

0.001

Length of hospital stay: days

22 [20.8]

33 [27.9]

0.003

  1. Data are no. (%) or mean [SD]
  2. * After six months of anti-tuberculous treatment, only 36 patients in the isolated pleurisy group and 72 in the pleuro-pulmonary group were still being followed in our hospital.